Titan Medical Inc. Retains New York-Based Bertner Advisors, LLC for Investor Relations Services
TORONTO, ONTARIO--(Marketwired - June 17, 2014) - Titan Medical Inc. (" Titan " or the " Company ") (TSX VENTURE:TMD)(OTCQX:TITXF) announced today that it has retained Bertner Advisors, LLC as its investor relations advisor. Services to be provided in the United States to Titan by Bertner Advisors include counsel on investor relations strategy.
Headquartered in New York City, Bertner Advisors is a financial communications consulting firm providing strategic investor relations services to health care companies. The Titan Client Management Team providing these services includes Monique Kosse, Managing Director, and Lena Adams, Associate Director. Bertner Advisors, LLC is privately held and solely owned by Sherry L. Bertner, who founded the firm in 2013.
Sherry Bertner, Chief Executive Officer of Bertner Advisors, commented, "Our team is thrilled to partner with Titan Medical. We look forward to working with management to design and execute an investor relations strategy that includes introducing the Titan story to Wall Street."
John Hargrove, Chief Executive Officer of Titan, said, "We believe Bertner Advisors will enable us to extend our investor reach and to build awareness on Wall Street. The Firm is a perfect fit for Titan as we continue to move closer to commercialization of the SPORT™ Surgical System and will enhance a great team, a great technology and a tremendous opportunity."
The agreement for the engagement of Bertner Advisors will commence on July 7, 2014 for a term of 36 months. Bertner Advisors will be paid fees of US$20,000 per month for its services, with an annual increase of 5% on such monthly fee. An additional fee of six times the monthly fee shall be paid to Bertner Advisors in the event that a merger, acquisition, consolidation, or other transaction occurs, pursuant to which all or substantially all of the stock, assets, or other interests in Titan are sold or otherwise conveyed, and such transaction results in a new person or entity obtaining a fifty percent (50%) or greater ownership interest in or control over Titan.
The Company's current investor relations and financial communications services contract with Brooks Communications will end effective on June 30, 2014. Titan would like to take the opportunity to thank Beverly Brooks for her services to the Company.
About Bertner Advisors, LLC
Founded by Sherry Bertner, Bertner Advisors, LLC is a financial communications consulting firm providing strategic investor relations services to health care companies. For more information, visit http://bertneradvisors.com/ .
About Titan Medical Inc.
Titan Medical Inc. is a Canadian public company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (" MIS "). The Company's Single Port Orifice Robotic Technology, SPORT™ Surgical System, currently under development, comprises a surgeon-controlled robotic platform that includes a 3D vision system and interactive instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an interface to the robotic platform for controlling the interactive instruments and providing a 3D endoscopic view of inside a patient's body during MIS procedures. The SPORT™ Surgical System is being designed to expand robotic surgery into areas of surgical specialties and simple and complex procedures that are currently under-serviced, and to allow surgeons to perform procedures within small to medium size surgical spaces such as general surgery and cholecystectomy. For more information, visit the Company's website at www.titanmedicalinc.com .
Forward-Looking Statements
This news release contains "forward-looking statements" which reflect the current expectations of management of the Company's future growth, results of operations, performance and business prospects and opportunities. Wherever possible, words such as "may", "would", "could", "will", "anticipate", "believe", "plan", "expect", "intend", "estimate", "potential for" and similar expressions have been used to identify these forward-looking statements. These statements reflect management's current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the "Risk Factors " section of the Company's Annual Information Form dated April 4, 2014 (which may be viewed at www.sedar.com ). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Titan Medical Inc.
John Hargrove
Chairman and Chief Executive Officer
(416) 548-7522 (ext. 151)
john.hargrove@titanmedicalinc.com
www.titanmedicalinc.com
